vs
Side-by-side financial comparison of Allot Ltd. (ALLT) and Ceribell, Inc. (CBLL). Click either name above to swap in a different company.
Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $24.1M, roughly 1.0× Allot Ltd.). Allot Ltd. runs the higher net margin — -7.0% vs -54.6%, a 47.6% gap on every dollar of revenue. Allot Ltd. produced more free cash flow last quarter ($4.0M vs $-11.0M).
Allot Ltd., formerly Allot Communications, is an Israeli high-tech company that develops telecommunications software. The company is headquartered in Hod Hasharon, Israel.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
ALLT vs CBLL — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.1M | $24.8M |
| Net Profit | $-1.7M | $-13.5M |
| Gross Margin | 72.1% | 87.3% |
| Operating Margin | -1.7% | -58.9% |
| Net Margin | -7.0% | -54.6% |
| Revenue YoY | 8.5% | — |
| Net Profit YoY | 49.6% | — |
| EPS (diluted) | $-0.04 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $24.8M | ||
| Q3 25 | — | $22.6M | ||
| Q2 25 | $24.1M | $21.2M | ||
| Q1 25 | $23.1M | $20.5M | ||
| Q3 24 | — | $17.2M | ||
| Q2 24 | $22.2M | — | ||
| Q2 23 | $25.0M | — | ||
| Q2 22 | $32.8M | — |
| Q4 25 | — | $-13.5M | ||
| Q3 25 | — | $-13.5M | ||
| Q2 25 | $-1.7M | $-13.6M | ||
| Q1 25 | $-332.0K | $-12.8M | ||
| Q3 24 | — | $-10.4M | ||
| Q2 24 | $-3.4M | — | ||
| Q2 23 | $-20.7M | — | ||
| Q2 22 | $-6.2M | — |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 88.3% | ||
| Q2 25 | 72.1% | 88.1% | ||
| Q1 25 | 69.3% | 87.9% | ||
| Q3 24 | — | 87.3% | ||
| Q2 24 | 68.5% | — | ||
| Q2 23 | 69.2% | — | ||
| Q2 22 | 68.7% | — |
| Q4 25 | — | -58.9% | ||
| Q3 25 | — | -64.8% | ||
| Q2 25 | -1.7% | -70.5% | ||
| Q1 25 | -3.1% | -69.3% | ||
| Q3 24 | — | -57.8% | ||
| Q2 24 | -15.2% | — | ||
| Q2 23 | -85.8% | — | ||
| Q2 22 | -19.8% | — |
| Q4 25 | — | -54.6% | ||
| Q3 25 | — | -59.6% | ||
| Q2 25 | -7.0% | -64.4% | ||
| Q1 25 | -1.4% | -62.4% | ||
| Q3 24 | — | -60.6% | ||
| Q2 24 | -15.1% | — | ||
| Q2 23 | -82.8% | — | ||
| Q2 22 | -19.0% | — |
| Q4 25 | — | $-0.35 | ||
| Q3 25 | — | $-0.37 | ||
| Q2 25 | $-0.04 | $-0.38 | ||
| Q1 25 | $-0.01 | $-0.36 | ||
| Q3 24 | — | $-1.85 | ||
| Q2 24 | $-0.09 | — | ||
| Q2 23 | $-0.55 | — | ||
| Q2 22 | $-0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.1M | $159.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $99.7M | $155.3M |
| Total Assets | $154.1M | $195.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $159.3M | ||
| Q3 25 | — | $168.5M | ||
| Q2 25 | $60.1M | $177.4M | ||
| Q1 25 | $10.1M | $182.7M | ||
| Q3 24 | — | $14.1M | ||
| Q2 24 | $15.9M | — | ||
| Q2 23 | $15.5M | — | ||
| Q2 22 | $15.5M | — |
| Q4 25 | — | $155.3M | ||
| Q3 25 | — | $164.1M | ||
| Q2 25 | $99.7M | $172.2M | ||
| Q1 25 | $50.0M | $180.9M | ||
| Q3 24 | — | $-136.0M | ||
| Q2 24 | $46.7M | — | ||
| Q2 23 | $76.1M | — | ||
| Q2 22 | $114.4M | — |
| Q4 25 | — | $195.8M | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | $154.1M | $207.7M | ||
| Q1 25 | $140.3M | $213.5M | ||
| Q3 24 | — | $47.1M | ||
| Q2 24 | $132.5M | — | ||
| Q2 23 | $177.8M | — | ||
| Q2 22 | $229.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $-10.8M |
| Free Cash FlowOCF − Capex | $4.0M | $-11.0M |
| FCF MarginFCF / Revenue | 16.5% | -44.2% |
| Capex IntensityCapex / Revenue | 1.7% | 0.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-6.0M | $-41.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-10.8M | ||
| Q3 25 | — | $-11.1M | ||
| Q2 25 | $4.4M | $-7.5M | ||
| Q1 25 | $1.7M | $-11.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.2M | — | ||
| Q2 23 | $-11.3M | — | ||
| Q2 22 | $-7.8M | — |
| Q4 25 | — | $-11.0M | ||
| Q3 25 | — | $-11.5M | ||
| Q2 25 | $4.0M | $-7.6M | ||
| Q1 25 | $1.4M | $-11.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | $217.0K | — | ||
| Q2 23 | $-11.6M | — | ||
| Q2 22 | $-9.1M | — |
| Q4 25 | — | -44.2% | ||
| Q3 25 | — | -50.8% | ||
| Q2 25 | 16.5% | -35.9% | ||
| Q1 25 | 6.1% | -56.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.0% | — | ||
| Q2 23 | -46.4% | — | ||
| Q2 22 | -27.7% | — |
| Q4 25 | — | 0.7% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | 1.7% | 0.3% | ||
| Q1 25 | 1.2% | 0.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.3% | — | ||
| Q2 23 | 1.2% | — | ||
| Q2 22 | 3.9% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALLT
Segment breakdown not available.
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
